Catalyst Wire Dossier Catalyst Wire Dossier

Moxifloxacin ophthalmic solution 0.5%

moxifloxacin hydrochloride · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Moxifloxacin ophthalmic solution 0.5%, covering 2009-08-26 to 2024-05-09. Get the full timeline:

Most recent: Clinical Trial Update: Effectiveness and Safety of 0.5% Moxifloxacin Hydrochloride Ophthalmic Solution in Perioperative Sterilization in Patients Undergoing Ophthalmic Surgery

See pricing